|
MTERFD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.01900734914307E-14 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
2.749400E-01 |
| Stage1-vs-Stage3 |
1.770200E-01 |
| Stage1-vs-Stage4 |
1.76116999999198E-05 |
| Stage2-vs-Stage3 |
6.833600E-02 |
| Stage2-vs-Stage4 |
1.080270E-03 |
| Stage3-vs-Stage4 |
5.618300E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.46059830896661E-11 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
1.976960E-01 |
| Caucasian-vs-Asian |
1.098020E-01 |
| AfricanAmerican-vs-Asian |
7.498600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
8.261800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
5.81449999259576E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.214000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.526000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.666400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.244000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.029600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.554800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.750630E-04 |
| Classical-VS-Follicular |
4.419900E-03 |
| Classical-VS-Other |
8.300600E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
2.61680000002151E-07 |
| Tall-VS-Other |
2.114600E-01 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
4.628800E-01 |
| Follicular-VS-Normal |
1.6251444634463E-12 |
| Other-VS-Normal |
6.50850000005754E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
3.980900E-03 |
|
|
